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Abstract
Background: Influenza causes considerable morbidity and mortality in China, but its impact on the health-related
quality of life (HRQoL) has not been previously measured.
Methods: We conducted a retrospective telephone survey to assess the impact of influenza on the HRQoL among
outpatients and inpatients using the EuroQoL EQ-5D-3 L instrument. Participants were individuals with laboratory-
confirmed influenza infection registered by the National Influenza-like-illness Surveillance Network in 2013.
Results: We interviewed 839 of 11,098 eligible influenza patients. After excluding those who were unable to
complete the HRQoL for the registered influenza episode, 778 patients were included in the analysis. Both
outpatients (n = 529) and inpatients (n = 249) most commonly reported problems with pain/discomfort (71.8% of
outpatients and 71.9% of inpatients) and anxiety/depression (62.0% of outpatients and 75.1% of inpatients). For
individual influenza outpatients, the mean health utility was 0.6142 (SD 0.2006), and the average quality adjusted
life days (QALD) loss was 1.62 (SD 1.84) days. The HRQoL of influenza inpatients was worse (mean health utility 0.
5851, SD 0.2197; mean QALD loss 3.51 days, SD 4.25) than that of outpatients (p < 0.05). The presence of underlying
medical conditions lowered the HRQoL for both outpatients and inpatients (p < 0.05).
Conclusions: Influenza illness had a substantial impact on HRQoL. QALD loss due to an acute influenza episode in
younger children was comparable to that due to enterovirus A71-associated hand, foot and mouth disease. Our
findings are key inputs into disease burden estimates and cost-effectiveness evaluations of influenza-related
interventions in China.
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Background
Influenza virus causes substantial morbidity and mortal-
ity in China, with an estimated 115–142 hospitalizations
associated with severe acute respiratory infections
(SARI) per 100,000 population, and 7.0–14.3 influenza
associated respiratory and circulatory excess deaths per
100,000 persons every year [1, 2]. The World Health
Organization recommends influenza vaccination for re-
ducing influenza burden [3], but China has yet to
implement a nationwide influenza vaccination programme
for any risk group. To inform such a decision, the
vaccine-preventable burden of influenza will need to be
evaluated against other diseases with interventions that
are competing for health care resources.
Previous reports have estimated influenza incidence
and mortality, but none of them have investigated the
impact of influenza on health-related quality of life
(HRQoL) in China. HRQoL measures such as quality ad-
justed life years combine measures of morbidity and
mortality into a single unit, hence enabling comparisons
between diseases of varying incidence and severity. This
information will be useful for parameterizing compara-
tive analysis of interventions for influenza.
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HRQoL can be measured using generic preference-
based instruments such as the EuroQoL EQ-5D [4]. Two
recent systematic reviews of studies measuring HRQoL
associated with influenza [5, 6] had identified only seven
original studies. The number of quality adjusted life days
(QALDs) lost as a result of a single influenza episode
(measured as 1/365 × quality adjusted life years lost)
across these studies ranged widely between 1.68–17.34.
None of the reviewed studies was conducted in China.
HRQoL measurements from other countries is unlikely to
be directly applicable in China because the utilities associ-
ated with different health states are likely to be influenced
by cultural perceptions and preferences [7, 8].
To address this evidence gap, we conducted a sur-
vey to estimate the QALDs losses as a result of a sin-
gle influenza episode resulting in either outpatient or
inpatient hospital attendance. This provides essential
information for decision makers to understand the
magnitude of influenza burden in China compared to
other diseases and evaluate interventions such as
vaccination.
Methods
A telephone investigation was conducted from 25
December 2013 to 11 January 2014 among influenza
patients registered in the National Influenza-like-
illness Surveillance Network (ILINet) in China. The
survey was performed alongside a parallel survey
among the same participants on the economic cost
of influenza illness [9]. Participants were laboratory-
confirmed influenza patients with landline or mobile
phone numbers registered in the ILINet in 2013. We
solicited the demographic (e.g. name, age, gender,
address), clinical (e.g. date of onset, hospital visit
date) and virological detection details of each patient
from ILINet.
ILINet is a network of 408 provincial- and prefecture-
level Centers for Disease Control and Prevention and 554
sentinel hospitals situated in 31 provinces [10]. It was
established to monitor the activity, antigenic and genetic
changes in seasonal influenza viruses in China. Specimens
are then tested for influenza virus using cell culture and/
or reverse transcription polymerase chain reaction (RT-
PCR). Positive influenza specimens are typed and sub-
typed using RT-PCR. Assay kits and protocols follow
guidelines released by the Chinese National Influenza
Centre (a World Health Organization Collaborating
Centre for Reference and Research on Influenza).
EQ-5D instrument and telephone survey
The EuroQoL EQ-5D-3 L (hereafter just “EQ-5D”) is a
widely used generic instrument for measuring non-
disease-specific HRQoL. It comprises of a visual
analogue scale (VAS) and a descriptive system. The VAS
records the health status on a scale between zero (the
worst imaginable health state) and 100 (the best imagin-
able health state). The EQ-5D descriptive system defines
health in five dimensions: mobility, self-care, usual activ-
ities, pain/discomfort, and anxiety/depression. Each di-
mension has three categories: no problems, some
problems and extreme problems. The health states de-
fined by EQ-5D descriptive system can be converted into
a numerical health utility score using country-specific
value sets, by eliciting choices between different health
states from each country’s populations, with zero repre-
senting death and one representing full health [4]. Nega-
tive values correspond to states considered to be less
preferred than death.
We used the EQ-5D telephone interview version in
simplified Chinese [11] for adult patients (aged 16 years
and above) who could be reached by telephone. For pa-
tients younger than 16 years old and other patients for
whom only the contact information of a caregiver was
available, we used a slightly altered EQ-5D proxy version
[11] (telephone-based proxy version: proxy 2, in which
their caregivers were asked to rate how they believed the
patients would rate their own HRQoL; available on re-
quest). For children younger than 18 months, the mobil-
ity and self-care dimensions were not scored because
not all young children at these ages are able to walk and
all of them are unable to care for themselves [12]. For
these participants, the mobility and self-care dimensions
were both given the value of “no problems” in the base-
line analysis and “extreme problems” in a sensitivity
analysis.
The telephone survey was conducted as follows: after
obtaining verbal informed consent, a trained interviewer
verified the respondent’s basic information recorded
in the surveillance systems, including her/his name,
age, gender, and the date of onset of illness. If veri-
fied and if the respondent was able to recall the influ-
enza episode, the respondent was asked to complete
the EQ-5D survey based upon the average day of
their illness over the telephone, and to give the dur-
ation of influenza symptoms. Otherwise, she/he was
excluded from the study. Each telephone number was
called up to four times on different days before being
classified as unreachable. A more detailed description
of the study design has been reported in our earlier
publication [9].
Data analysis
Data analysis was performed using R version 3.0.3 [13].
Responses to the EQ-5D descriptive system were con-
verted into health utilities using China-specific tariffs de-
veloped using regression models fitted to time trade-offs
for respondents presented with different health states
[14]. A range of models were fitted by the authors of
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Chinese time trade-off values for EQ-5D health states
(Value Health 2014); we used the tariffs corresponding
to the model using ordinary least squares regression on
aggregate data, which had the lowest adjusted R2 of all
the models (i.e., the “N3 model”) [14]. The model in-
cludes 11 dummy variables for specifying the problems
in a health state: 1) with the MO2, SC2, UA2, PD2 and
AD2 terms being 1(0) for the presence (absence) of
moderate problems in mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression, respectively; 2)
with MO3, SC3, UA3, PD3 and AD3 terms being 1(0)
for the presence (absence) of extreme problems in these
dimensions; 3) with N3 term being 1(0) for the presence
(absence) of any extreme problems; 4) coefficients for
MO2, SC2, UA2, PD2, AD2, MO3, SC3, UA3, PD3, AD3
and N3 were 0.099, 0.105, 0.074, 0.092, 0.086, 0.246,
0.208, 0.193, 0.236, 0.205, 0.022, respectively; 5) with a
constant coefficient being 0.039 [14]. Utility scores were
then converted into QALD losses by multiplying the dif-
ference in health utility during the influenza episode
from background health utility by the reported duration
of illness. The health utility of general population across
China was not available. We used the average (0.86) of
background health utility of rural residents in western
China [15] and influenza patients from other countries
(UK and Spain) [5, 15–17] as controls to compare with
that of influenza patients in our study (more details
shown in Additional file 1).
Results were stratified by age, gender, risk status (high
risk patients refer to those with underlying medical con-
ditions including: chronic respiratory disease, asthma,
chronic cardiovascular diseases, diabetes, chronic liver
disease, and chronic renal disease, etc. Other patients
without these underlying diseases are low risk patients
[3]), urban or rural residence (as previously defined [9]),
economic development region (East, Central, and West)
(see Additional file 2: Fig. S1) [18], hospital level (distin-
guished by numbers of beds, health-care workers, facil-
ities and equipment, etc., as previously defined [9] and
details also shown in Additional file 3), and virus type
(influenza A, influenza B, and influenza untyped, with
the latter corresponding to samples for which influenza
virus typing was not conducted).
We used bootstrap multiple linear regression (with
1000 replications) to analyse the determinants of the
VAS score, as well as health utility and QALD loss cal-
culated from the descriptive system, in other words, to
evaluate the role of socio-demographic (e.g., age and
gender) and other variables (e.g., risk status, influenza
type) on the rating of VAS score, health utility and on
QALD loss. The Chi-Square test or Fisher’s Exact test
were used for qualitative variables. It was found that
population structure (by age group and levels of hospi-
tals) of included patients was significantly different from
that of other influenza patients from the National ILINet
(details shown in Additional file 4: Table S1). Hence we
calculated the weighted HRQoL of included patients
using the population structure of the surveillance net-
work as a reference.
Results
Characteristics of enrolled patients
Of 39,968 laboratory-confirmed influenza patients regis-
tered in the National ILINet, 11,098 influenza patients
with telephone numbers registered were eligible, and
778 patients who were successfully interviewed (529 out-
patients and 249 inpatients) were included in the ana-
lysis. Statistically significant differences in age and
hospital level but not in gender and region were ob-
served between included (n = 778) and excluded influ-
enza patients (n = 39,190) from the surveillance network
(Additional file 4: Table S1). Further details including a
flow diagram of participant selection have been previ-
ously published [9].
The median age of included respondents was seven
years (interquartile range, IQR 3–15), with 589 (75.7%)
respondents younger than 16 years of age. 438 (82.8%)
outpatients and 166 (66.7%) inpatients were from urban
areas. 117 (22.1%) outpatients and 131 (52.6%) inpatients
had underlying medical conditions. 271 (51.2%) outpa-
tients and 113 (45.4%) inpatients were from East China.
(Table 1) The average duration of an influenza episode
was 6.2 (standard deviation, SD 3.5) days and 11.8 (SD
7.5) days respectively for influenza outpatients and
inpatients.
EQ-5D dimension results
Both influenza outpatients and inpatients reported prob-
lems on all five dimensions measured in the EQ-5D.
Problems with pain/discomfort (71.8% of outpatients
and 71.9% of inpatients) and anxiety/depression (62.0%
of outpatients and 75.1% of inpatients) were the most
commonly reported. Relatively fewer patients (below
40% of both outpatients and inpatients) reported prob-
lems with mobility, self-care, and usual activity. The pro-
portions of patients reporting severe problems on any
dimension were quite low (below 10%, apart from pain/
discomfort). Problems with pain/discomfort and anxiety/
depression were also the most commonly reported
across different strata of patients. (Fig. 1).
HRQoL of influenza patients
Average values for VAS, health utilities and QALD losses
for both inpatients and outpatients are shown in Table 2.
The HRQoL of inpatients was significantly worse on all
three measures (p < 0.05). When weighted by population
structure (in terms of age and hospital level), the re-
ported HRQoL of outpatients and inpatients changed
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slightly. Multiple linear regression indicated having under-
lying diseases was significantly associated with greater
QALD losses in both outpatients and inpatients (p < 0.05).
In addition, being female or from West China was signifi-
cantly associated with greater QALD losses in outpatients,
and less QALD losses observed in influenza A inpatients.
More details were presented in Tables 3 and 4.
There were 35 (6.6%) influenza outpatients and 56
(22%) influenza inpatients younger than 18 months. The
mobility and self-care domains of these patients were
not elicited, and were given scores corresponding to no
problems and severe problems respectively in the base-
line analysis and sensitivity analysis. HRQoL measures
were much more severe in the sensitivity analysis in
both outpatients (health utility 0.1651, QALD loss 5.05
compared to health utility 0.6235, QALD loss 1.78) and
inpatients (health utility 0.1556, QALD loss 8.72
compared to health utility 0.6152, QALD loss 3.11).
However, due to the small proportions of these younger
patients, we found that the uncertainty in their mobility
and self-care domains had slightly impact on HRQoL for
all outpatients (health utility 0.5838, QALD loss 1.84
compared to health utility 0.6142, QALD loss 1.62) and
inpatients (health utility 0.4817, QALD loss 4.77 com-
pared to health utility 0.5851, QALD loss 3.51).
In patients aged 16 years and above, there were no
significant differences in VAS, health utility or QALD
loss between those who filled in the EQ-5D for them-
selves and those who had it filled in by proxy
(p > 0.05). (Additional file 5: Table S2).
Discussion and conclusion
This is the first study to explore the HRQoL impact of
influenza in China. We found influenza was associated
Table 1 Characteristics of included influenza patients in the health-related quality of life survey, China, 2013 (n, %)
Characteristics Influenza outpatients
(n = 529)
Influenza inpatients
(n = 249)
Total
(n = 778)
Median age, years (IQR) a 8 (5–20) 4 (2–7) 7 (3–15)
Age group, years
< 5 122 (23.1%) 141 (56.6%) 263 (33.8%)
5–15 246 (46.5%) 80 (32.1%) 326 (41.9%)
16–59 146 (27.6%) 24 (9.6%) 170 (21.9%)
≥ 60 15 (2.8%) 4 (1.6%) 19 (2.4%)
Male 281 (53.1%) 144 (57.8%) 425 (54.6%)
Risk status b
Low-risk 412 (77.9%) 118 (47.4%) 530 (68.1%)
High-risk 117 (22.1%) 131 (52.6%) 248 (31.9%)
Area
Urban area 438 (82.8%) 166 (66.7%) 604 (77.6%)
Rural area 91 (17.2%) 83 (33.3%) 174 (22.4%)
Region
East China 271 (51.2%) 113 (45.4%) 384 (49.4%)
Central China 122 (23.1%) 78 (31.3%) 200 (25.7%)
West China 136 (25.7%) 58 (23.3%) 194 (24.9%)
Hospital c
Level 3 298 (56.3%) 177 (69.7%) 475 (60.7%)
Level 2 119 (22.5%) 58 (22.8%) 177 (22.6%)
Level 1 and lower 112 (21.2%) 19 (7.5%) 131 (16.7%)
Virus type
Untyped d 307 (58.0%) 183 (73.5%) 490 (63.0%)
Influenza A 164 (31.0%) 30 (12.0%) 194 (24.9%)
Influenza B 58 (11.0%) 36 (14.5%) 94 (12.1%)
a IQR: inter-quartile range
b Risk status: high risk patients refer to those with underlying medical conditions including: chronic respiratory disease, asthma, chronic cardiovascular diseases,
diabetes, chronic liver disease, and chronic renal disease, etc. Other patients without these underlying diseases are low risk patients
c Level 3 is the top level, followed by level 2 and level 1 in order
d Untyped: Laboratory tests for influenza virus type identification were not conducted
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with a mean QALD loss of 1.62 in outpatients and 3.51
in inpatients. In the children younger than five years, the
QALD loss during an influenza episode was 1.72 days
for outpatients and 3.51 days for inpatients (see Tables 3
and 4). This is similar to the HRQoL impact of other
acute infectious diseases of national importance in chil-
dren such as enterovirus 71-associated hand, foot and
mouth disease (with QALD loss of 1.31–2.99 days for
outpatients, and 5.44 days for inpatients [19]). Although
the duration of influenza symptoms is much shorter, the
health utility of patients during an acute influenza epi-
sode (≥60 years old: 0.4128–0.5733, and 16–59 years
old: 0.4913–0.5939) is worse than that of patients with
chronic diseases such as diabetes (≥60 years old: 0.865,
and 18–59 years old: 0.902 [20]) and active chronic
hepatitis B (≥18 years old: 0.773 [21]). Some of the influ-
enza patients included in our analysis may have compli-
cations. It was expected that HRQoL of complicated
influenza patients was worse than that of uncomplicated
influenza. However, we were unable to distinguish
HRQoL between influenza patients with and without
complications since the complications were not available
for the patients from ILINet. The HRQoL stratified by
complicated and uncomplicated influenza patients merit
further investigation in the future.
We used the standard EQ-5D instrument (telephone
version) for 76.0% of adult patients aged 16 years and
above who could be reached by telephone, and used the
EQ-5D telephone-based proxy version for 24.0% of adult
patients for whom only the caregivers’ contact
Fig. 1 Ratings by EQ-5D dimension for influenza outpatients and inpatients. Not scored: For all the influenza patients younger than 18 months,
the mobility and self-care dimensions were not scored and assumed to be no problem in the baseline analysis of health-related quality of life
Table 2 Health-related quality of life of influenza outpatients and inpatients
n VAS Health utility QALD loss a
Mean
(SD)
Median
(IQR)
Mean
(SD)
Median
(IQR)
Mean
(SD)
Median
(IQR)
Influenza outpatient
Unweighted 529 68.93 (19.08) 70.00 (60.00, 80.00) 0.6142 (0.2006) 0.6430 (0.5630, 0.7350) 1.62 (1.84) 1.08 (0.46, 2.04)
Weightedb 529 68.20 (35.98) 66.18 (42.05, 87.34) 0.6087 (0.3518) 0.5678 (0.3333, 0.7532) 1.69 (2.52) 0.94 (0.39, 1.94)
Influenza inpatient
Unweighted 249 65.94 (20.61) 70.00 (50.00, 80.00) 0.5851 (0.2197) 0.6430 (0.4770, 0.7290) 3.51 (4.25) 2.17 (1.00, 4.45)
Weightedb 249 64.07 (29.03) 60.83 (43.45, 78.22) 0.5616 (0.2799) 0.5588 (0.3846, 0.6925) 3.63 (5.53) 2.03 (0.80, 3.93)
a QALD: quality-adjusted life days
b Weighted: Previous analysis showed that population structure (by age group and levels of hospitals) of included patients was significantly different from that of
other influenza patients from the National ILI Surveillance Network [Additional file 4: Table S1]. Hence we calculated the weighted HRQoL of included patients
using the population structure of the National ILI Surveillance Network as a reference
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information is available and for all children younger than
16 years of age. We compared the HRQoL of adult pa-
tients between the self-reported and proxy-reported
groups, and found that the EQ-5D telephone-based
proxy version gave similar values of HRQoL when com-
pared to the standard EQ-5D telephone version for adult
patients (when factors like age, gender, presence of
underlying diseases were controlled for). Previous publi-
cations found that proxy EQ-5D responses only had a
mild to moderate agreement with the patients’ responses
[22–26]. Compared to them, our study seems to have
performed better in this respect than other proxy stud-
ies. We note that the EQ-5D is generally thought to be
valid only for populations older than 12 years and the
EQ-5D-Y only for children older than 8 years [27]. For
other younger children, the reliability and validity of
child-report health information are often questinable
due to their developmental stage, language ability, and
congitive functioning [28]. Therefore, we used the EQ-
5D proxy version as an alternative in this study to rate
the quality of life for all children.
A study on the effect of measles on HRQoL in UK
found that 40% and 70% of proxy respondents did not
answer the mobility and self-care dimensions respect-
ively in the EQ-5D questionnaire to evaluate a young
child’s HRQoL [12]. Therefore, the mobility and self-
care dimensions for influenza patients younger than
18 months were not scored in our telephone survey.
Sensitivity analysis showed that the HRQoL for these
outpatients younger than 18 months varied greatly when
these younger children were assumed to be severe prob-
lem compared to no problem. However, the overall
HRQoL of all influenza outpatients and inpatients was
not sensitive to variations in this assumption due to the
small proportions of patients younger than 18 months in
the surveillance network datasets.
Compared to influenza patients from the National ILI-
Net who did not participate in the study, more influenza
patients included in our analysis were younger than
16 years old (75.7% vs. 61.1%). Due to unavailability of
characteristics of all influenza patients at a national level,
we could not precisely determine how well our sample
represents all influenza patients in China and not
generalize our results to that at the national level. In-
stead, we weighted HRQoL of included patients using
the population structure of the National ILINet as a ref-
erence, in order that our results could represent the
HRQoL of all influenza patients registered in the Na-
tional ILINet. Moreover, the multiple linear regression
showed that no significant differences in HRQoL was
observed between age groups (Tables 3 and 4). Thus,
even if the children were over-represented, it would not
have a big impact on the HRQoL of overall study partici-
pants. Another point of concern was that the high-level
hospitals were overrepresented in the surveillance sys-
tem, which do not cover basic medical institutions [9].
Patients with severe influenza are more likely to seek
medical care in high-level hospitals than those with mild
influenza who prefer basic medical institutions or prac-
tice self-care at home. Accordingly, patients with severe
influenza may be overrepresented in our survey, which
may result in an overestimation of the impact of influ-
enza on HRQoL.
This study has several limitations. First, we asked re-
spondents to evaluate their average HRQoL of all days
during their influenza episode (other than that for a spe-
cific day like the worst day for the illness) and assumed
that the health utility dropped to this level from day one
of infection and remained constant, then returned to its
highest level upon recovery. It was likely the study par-
ticipants rated the impact of influenza infection on
HRQoL for the worst day of infection instead. In this
case, we assumed that the impact of influenza infection
on HRQoL can be described by a triangular shape,
which means the health utility linearly dropped to the
worst level, and then linearly increased to the highest
level. This reduced the QALD loss by half. Ideally, we
would collect HRQoL information prospectively from
patients, which would allow us to take several measure-
ments to track how HRQoL changes over the course of
the influenza episode, allowing more accurate estimation
of QALD loss. Further prospective studies in the direc-
tion should make sense.
Second, it was impossible for us to rate the back-
ground health utility before influenza infections in the
retrospective study, and there were no datasets measur-
ing the HRQoL of the general population across China
that could be used as controls to compare with our sam-
ple of patients with influenza. Hence, we calculated the
QALD losses of influenza patients based on the differ-
ence between their health utility and the average of
other populations (health utility: 0.86) [5, 15–17]. Due to
the potential difference of health status and cultural per-
ceptions between our study population and rural resi-
dents in western China as well as population from other
countries, the estimation of QALD losses would be
biased. As aforementioned, future prospective studies
with several measurements during and after an influenza
episode is necessary.
Third, since National ILINet report patients with ele-
vated temperature. However, a substantial population of
influenza patients aged 60 years old and above do not
have fever [29, 30]. That may be related to the very low
proportion (4.1%) of elderly influenza patients reported
in the surveillance network [9], and accordingly result in
limited number (n = 19, 2.4% of all study population) of
elderly participants in our study. Because the elderly
were more likely to have underlying medical conditions
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which have been found to be significantly related with
greater QALD losses in this study, we may underesti-
mate the impact of influenza on HRQoL with limited
number of elderly participants.
Fourth, our respondents may have been subject to re-
call bias since they were asked to complete the EQ-5D
retrospectively (The time between the influenza episode
and interview was less than 46 days for 50% of our study
participants [9]) rather than during their episode. We
split study population into four groups on the basis of
the 25th, 50th, 75th and 100th percentiles of the time
delay between survey and the actual influenza episode,
and did not found significant difference in HRQoL be-
tween them (data shown in Additional file 6: Table S3).
Lastly, a high proportion (32%) of participants were in-
fluenza inpatients in our study. It was found that the
HRQoL of influenza inpatients was much more im-
pacted in comparison with influenza outpatients, with
worse health utility and higher QALD loss. It revealed
that more severe influenza patients may be more willing
to take part in the survey. That maybe probably because
they have a deeper insight and memory into the episode
of influenza infection. The possible selection bias may
lead to overestimating the health impact of influenza
infections.
Despite these limitations, this study is the first attempt
to measure the HRQoL of influenza patients in China.
Influenza illness had a substantial impact on HRQoL.
Our findings are important inputs for burden of disease
studies and health economic evaluations of influenza-
related interventions such as vaccination. These in turn
are essential to inform decision making on the distribu-
tion of health care resources, since they enable compari-
sons between diseases of varying incidence and severity.
Additional files
Additional file 1: Overview of published estimates of background
health weight for influenza patients. (DOCX 23 kb)
Additional file 2: Figure S1. Map of geographic regions in mainland
China. (TIFF 1033 kb)
Additional file 3: Definition of hospital levels. (DOCX 19 kb)
Additional file 4: Table S1. Characteristics of included patients and
other lab-confirmed influenza patients from the National ILI Surveillance
Network in the survey. (DOCX 25 kb)
Additional file 5: Table S2. Comparison of the health-related quality of
life for influenza patients aged 16 years and above between the self-report
and proxy-report groups. (DOCX 22 kb)
Additional file 6: Table S3. Health-related quality of life of influenza
patients stratified by time delay between survey and the influenza
episode. (DOCX 32 kb)
Abbreviations
EQ-5D: EuroQoL EQ-5D-3 L; HRQoL: Health-related quality of life;
ILINet: National Influenza-like-illness Surveillance Network; QALDs: Quality
adjusted life days; RT-PCR: Reverse transcription polymerase chain reaction;
SARI: Severe acute respiratory infections; VAS: Visual analogue scale
Acknowledgements
We sincerely thank Dr. Mark Simmerman from Sanofi Pasteur for the valuable
comments to the revision of the manuscript.
Funding
This study was supported by grants from the National Science Fund for
Distinguished Young Scholars (grant no. 81525023), the Harvard Center for
Communicable Disease Dynamics from the National Institute of General
Medical Sciences (grant no. U54 GM088558) and a commissioned grant from
the Health and Medical Research Fund, Food and Health Bureau, Government
of the Hong Kong Special Administrative Region. They have not influenced
the study design, data collection and analysis, and preparation of the
manuscript.
Availability of data and materials
The datasets used and/or analysed is this study are available from the
corresponding author on reasonable request.
Authors’ contributions
JY, MJ, JTW, YMZ and HJY designed the analysis; JY, YMZ, LZF and XXL
conducted the telephone survey and collected data; JY did the data analysis
and wrote the first draft of the manuscript; all authors contributed to the
interpretation of the results and to the revision and final preparation of the
manuscript for submission. All authors read and approved the final manuscript.
Ethics approval and consent to participate
This study was approved by the Institutional Review Board of the Chinese
Center for Disease Control and Prevention (No. IRB 201417). Verbal informed
consent was obtained before interviews.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1School of Public Health, Fudan University, Key Laboratory of Public Health
Safety, Ministry of Education, Shanghai 200032, China. 2Key Laboratory of
Surveillance and Early-warning on Infectious Disease, Division of Infectious
Disease, Chinese Center for Disease Control and Prevention, Beijing 102206,
China. 3Modelling and Economics Unit, Public Health England, London, UK.
4Department of Infectious Disease Epidemiology, London School of Hygiene
and Tropical Medicine, London, UK. 5Economics, Department of Economics,
Emory University, Atlanta, USA. 6WHO Collaborating Centre for Infectious
Disease Epidemiology and Control, School of Public Health, Li Ka Shing
Faculty of Medicine, The University of Hong Kong, Hong Kong Special
Administrative Region, China.
Received: 15 March 2017 Accepted: 4 October 2017
References
1. Yu H, Huang J, Huai Y, Guan X, Klena J, Liu S, et al. The substantial burden
of pneumonia and influenza in central China: surveillance for severe, acute
respiratory infection and influenza viruses, 2010-2012. Influenza Other Respir
Viruses. 2014;8(1):53–65. doi:10.1111/irv.12205. Epub 2013 Nov 10.
2. Yu H, Feng L, Viboud CG, Shay DK, Jiang Y, Zhou H, et al. Regional variation
in mortality impact of the 2009 a(H1N1) influenza pandemic in China.
Influenza Other Respir Viruses. 2013;7(6):1350–60. doi:10.1111/irv.12121.
Epub 2013 May 13.
3. World Health Organiztion. Vaccines against influenza WHO position paper-
November 2012. Wkly Epidemiol Rec. 2012;87(47):461–76.
4. The EuroQol Group. EuroQol-a new facility for the measurement of health-
related quality of life. Health Policy. 1990;16(3):199–208.
5. van Hoek AJ, Underwood A, Jit M, MIller E, Edmunds WJ. The impact of
pandemic influenza H1N1 on health-related quality of life: a prospective
population based study. PLoS One. 2011;6(3):e17030. doi:10.1371/journal.
pone.0017030.
Yang et al. BMC Infectious Diseases  (2017) 17:686 Page 11 of 12
6. Herdman M, Cole A, Hoyle CK, Coles V, Carroll S, Devlin N. Sources and
characteristics of utility weights for economic evaluation of pediatric
vaccines: a systematic review. Value Health. 2016;19:255–66. doi:10.1016/j.
jval.2015.11.003. Epub 2015 Dec 29
7. Knies S, Evers SM, Candel MJ, Severens JL, Ament AJ. Utilities of the EQ-5D:
transferable or not? PharmacoEconomics. 2009;27(9):767–79.
8. Bailey H, Kind P. Preliminary findings of an investigation into the
relationship between national culture and EQ-5D value sets. Qual Life Res.
2010;19:1145–54. doi:10.1007/s11136-010-9678-5. Epub 2010 May 23.
9. Yang J, Jit M, Leung KS, Zheng Y, Feng L, Wang L, et al. The economic
burden of influenza-associated outpatient visits and hospitalizations in
China: a retrospective survey. Infect Dis Poverty. 2015;4:44. doi:10.1186/
s40249-015-0077-6.
10. Chinese Center for Disease Control and Prevention. National influenza
surveillance protocol (2010 version) [in Chinese]. Available: http://www.moh.
gov.cn/jkj/s3577/201009/3fa356d0f4834d408fde6c12891a6482.shtml.
Accessed 12 June 2014.
11. EuroQol Group. EQ-5D Products. Available: https://euroqol.org/. Accessed 25
Sept 2014.
12. Thorrington D, Ramsay M, van Hoek AJ, Edmunds WJ, Vivancos R, Bukasa A,
et al. The effect of measles on health-related quality of life: a patient-based
survey. PLoS One. 2014;9(9):e105153. doi:10.1371/journal.pone.0105153.
eCollection 2014.
13. Core Team R. R: a language and environment for statistical computing.
Vienna: R Foundation for Statistical Computing; 2014. Available: http://www.
r-project.org/. Accessed 1 May 2016
14. Liu G, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D
health states. Value Health. 2014;17(5):597–604. doi:10.1016/j.jval.2014.05.007.
Epub 2014 Jul 23.
15. Liu Y, Gao J. Study on the health-related quality of life of rural residents in
western China. [in Chinese]. Chinese Medical Ethics. 2010;23(4):100–1,105.
16. Griffin AD, Perry AS, Fleming DM. Cost-effectiveness analysis of inhaled
zanamivir in the treatment of influenza a and B in high-risk patients.
PharmacoEconomics. 2001;19(3):293–301.
17. Hollmann M, Garin O, Galante M, Ferrer M, Dominguez A, Alonso J. Impact of
influenza on health-related quality of life among confirmed (H1N1)2009 patients.
PLoS One. 2013;8(3):e60477. doi:10.1371/journal.pone.0060477.
18. National Bureau of Statistics of China. China Statistical Yearbook 2014: the
classification of East, Central and West China. Available: http://www.stats.
gov.cn/tjsj/ndsj/2014/indexch.htm. Accessed 11 Apr 2014.
19. JT W, Jit M, Zheng Y, Leung K, Xing W, Yang J, et al. Routine pediatric
enterovirus 71 vaccination in China: a cost-effectiveness analysis. PLoS Med.
2016;13(3):e1001975. doi:10.1371/journal.pmed.1001975. eCollection 2016.
20. Pan C, Sun H, Zhou H, Ma Q, Xu Y, Luo N, et al. Valuing health-related
quality of life in type 2 diabetes patients in China. Med Decis Mak. 2016;
36(2):234–41. doi:10.1177/0272989X15606903. Epub 2015 Sep 23
21. Jia Y, Cui F, Li L, Zhang D, Zhang G, Wang F, et al. Comparison between the
EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Qual Life Res. 2014;
23:2355–63. doi:10.1007/s11136-014-0670-3. Epub 2014 Mar 14
22. Matza LS, Secnik K, Mannix S, Sallee FR. Parent-proxy EQ-5D ratings of
children with attention-deficit hyperactivity disorder in the US and the UK.
PharmacoEconomics. 2005;23(8):777–90.
23. Gabbe BJ, Lyons RA, Sutherland AM, Hart MJ, Cameron PA. Level of
agreement between patient and proxy responses to the EQ-5D health
questionnaire 12 months after injury. J Trauma Acute Care Surg. 2012;72(4):
1102–5. doi:10.1097/TA.0b013e3182464503.
24. Dinglas VD, Gifford JM, Husain N, Colantuoni E, Needham DM. Quality of life
before intensive care using EQ-5D: patient versus proxy responses. Crit Care
Med. 2013;41(1):9–14. doi:10.1097/CCM.0b013e318265f340.
25. Devine A, Taylor SJ, Spencer A, Diaz-Ordaz K, Eldridge S, Underwood M. The
agreement between proxy and self-completed EQ-5D for care home
residents was better for index scores than individual domains. J Clin
Epidemiol. 2014;67(9):1035–43. doi:10.1016/j.jclinepi.2014.04.005. Epub 2014
May 15.
26. Noyes J, Edwards RT. EQ-5D for the assessment of health-related quality of
life and resource allocation in children: a systematic methodological review.
Value Health. 2011;14(8):1117–29. doi:10.1016/j.jval.2011.07.011. Epub 2011
Oct 22
27. Khanna R, Jariwala K, Bentley JP. Health utility assessment using EQ-5D
among caregivers of children with autism. Value Health. 2013;16(5):778–88.
doi:10.1016/j.jval.2013.04.007. Epub 2013 Jun 18.
28. Matza LS, Patrick DL, Riley AW, Alexander JJ, Rajmil L, Pleil AM, et al. ISPOR
TASK FORCE REPORTS. Pediatric patient-reported outcome instruments for
research to support medical product labeling: report of the ISPOR PRO good
research practices for the assessment of children and adolescents task force.
Value Health. 2013;16(4):46–79. doi:10.1016/j.jval.2013.04.004.
29. Falsey AR, Cunningham CK, Bark WH, Kouides RW, Yuen JB, Menegus M,
et al. Respiratory syncytial virus and influenza a infection in the hospitalized
elderly. J Infect Dis. 1995;172:389–94.
30. Walsh EE, Cox C, Falsey AR. Clinical features of influenza a virus infection in
older hospitalized persons. J Am Geriatr Soc. 2002;50:1498–503.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Yang et al. BMC Infectious Diseases  (2017) 17:686 Page 12 of 12
